The Largest Measles Outbreak, Including 38 Modified Measles and 22 Typical Measles Cases in Its Elimination Era in Yamagata, Japan, 2017
The incidence of modified measles (M-Me), characterized by milder symptoms than those of typical measles (T-Me), has been increasing in Japan. However, the outbreak dominated by M-Me cases has not been thoroughly investigated worldwide. The largest importation-related outbreak of measles with genoty...
Saved in:
Published in | Japanese Journal of Infectious Diseases Vol. 71; no. 6; pp. 413 - 418 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
30.11.2018
Japan Science and Technology Agency |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The incidence of modified measles (M-Me), characterized by milder symptoms than those of typical measles (T-Me), has been increasing in Japan. However, the outbreak dominated by M-Me cases has not been thoroughly investigated worldwide. The largest importation-related outbreak of measles with genotype D8 occurred in Yamagata Prefecture, Japan, from March to April 2017. This phenomenon was observed after Japan had achieved measles elimination in 2015. We confirmed 60 cases by detecting the genome of the measles virus (MeV). Among the cases, 38 were M-Me and 22 were T-Me. Thirty-nine (65.0%) patients were 20–39 years of age. Three out of 7 primary cases produced 50 transmissions, of which each patient caused 9–25 transmissions. These patients were 22–31 years old and were not vaccinated. Moreover, they developed T-Me and kept contact with the public during their symptomatic periods. Considering that M-Me is generally caused by vaccine failure, some individuals in Japan may have insufficient immunity for MeV. Accordingly, additional doses of measles vaccine may be necessary in preventing measles importation and endemicity among individuals aged 20–39 years. Furthermore, to accurately and promptly diagnose individuals with measles, particularly those who can be considered as primary cases, efforts must be exerted to detect all measles cases using epidemiological and genetic approaches in countries where measles elimination had been achieved. |
---|---|
AbstractList | The incidence of modified measles (M-Me), characterized by milder symptoms than those of typical measles (T-Me), has been increasing in Japan. However, the outbreak dominated by M-Me cases has not been thoroughly investigated worldwide. The largest importation-related outbreak of measles with genotype D8 occurred in Yamagata Prefecture, Japan, from March to April 2017. This phenomenon was observed after Japan had achieved measles elimination in 2015. We confirmed 60 cases by detecting the genome of the measles virus (MeV). Among the cases, 38 were M-Me and 22 were T-Me. Thirty-nine (65.0%) patients were 20–39 years of age. Three out of 7 primary cases produced 50 transmissions, of which each patient caused 9–25 transmissions. These patients were 22–31 years old and were not vaccinated. Moreover, they developed T-Me and kept contact with the public during their symptomatic periods. Considering that M-Me is generally caused by vaccine failure, some individuals in Japan may have insufficient immunity for MeV. Accordingly, additional doses of measles vaccine may be necessary in preventing measles importation and endemicity among individuals aged 20–39 years. Furthermore, to accurately and promptly diagnose individuals with measles, particularly those who can be considered as primary cases, efforts must be exerted to detect all measles cases using epidemiological and genetic approaches in countries where measles elimination had been achieved. The incidence of modified measles (M-Me), characterized by milder symptoms than those of typical measles (T-Me), has been increasing in Japan. However, the outbreak dominated by M-Me cases has not been thoroughly investigated worldwide. The largest importation-related outbreak of measles with genotype D8 occurred in Yamagata Prefecture, Japan, from March to April 2017. This phenomenon was observed after Japan had achieved measles elimination in 2015. We confirmed 60 cases by detecting the genome of the measles virus (MeV). Among the cases, 38 were M-Me and 22 were T-Me. Thirty-nine (65.0%) patients were 20-39 years of age. Three out of 7 primary cases produced 50 transmissions, of which each patient caused 9-25 transmissions. These patients were 22-31 years old and were not vaccinated. Moreover, they developed T-Me and kept contact with the public during their symptomatic periods. Considering that M-Me is generally caused by vaccine failure, some individuals in Japan may have insufficient immunity for MeV. Accordingly, additional doses of measles vaccine may be necessary in preventing measles importation and endemicity among individuals aged 20-39 years. Furthermore, to accurately and promptly diagnose individuals with measles, particularly those who can be considered as primary cases, efforts must be exerted to detect all measles cases using epidemiological and genetic approaches in countries where measles elimination had been achieved.The incidence of modified measles (M-Me), characterized by milder symptoms than those of typical measles (T-Me), has been increasing in Japan. However, the outbreak dominated by M-Me cases has not been thoroughly investigated worldwide. The largest importation-related outbreak of measles with genotype D8 occurred in Yamagata Prefecture, Japan, from March to April 2017. This phenomenon was observed after Japan had achieved measles elimination in 2015. We confirmed 60 cases by detecting the genome of the measles virus (MeV). Among the cases, 38 were M-Me and 22 were T-Me. Thirty-nine (65.0%) patients were 20-39 years of age. Three out of 7 primary cases produced 50 transmissions, of which each patient caused 9-25 transmissions. These patients were 22-31 years old and were not vaccinated. Moreover, they developed T-Me and kept contact with the public during their symptomatic periods. Considering that M-Me is generally caused by vaccine failure, some individuals in Japan may have insufficient immunity for MeV. Accordingly, additional doses of measles vaccine may be necessary in preventing measles importation and endemicity among individuals aged 20-39 years. Furthermore, to accurately and promptly diagnose individuals with measles, particularly those who can be considered as primary cases, efforts must be exerted to detect all measles cases using epidemiological and genetic approaches in countries where measles elimination had been achieved. |
Author | Onuki, Noriko Komabayashi, Kenichi Ikeda, Tatsuya Ahiko, Tadayuki Seto, Junji Suzuki, Yu Ishikawa, Hitoshi Mizuta, Katsumi Tanaka, Shizuka Yamada, Keiko |
Author_xml | – sequence: 1 fullname: Komabayashi, Kenichi organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health – sequence: 2 fullname: Seto, Junji organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health – sequence: 3 fullname: Tanaka, Shizuka organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health – sequence: 4 fullname: Suzuki, Yu organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health – sequence: 5 fullname: Ikeda, Tatsuya organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health – sequence: 6 fullname: Onuki, Noriko organization: Yamagata Prefecture Division of Health and Welfare Planning – sequence: 7 fullname: Yamada, Keiko organization: Okitama Public Health Center – sequence: 8 fullname: Ahiko, Tadayuki organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health – sequence: 9 fullname: Ishikawa, Hitoshi organization: Shonai Public Health Center – sequence: 10 fullname: Mizuta, Katsumi organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29962488$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kb9u2zAQh4UiRfOnfYICBYEuHSyXIimKGgvXSWU4yOIOnYgTRTl0JMolqcFv0McuFTsGmqHLkTh8H3G833VyYQerk-RjhueFEPTrYXjSdr5aVd_nBGdijgV9k1xlQrCUCMov4p0ylnKK2WVy7f0OY5LnGX6XXJKy5IQJcZX82TxqtAa31T6gew2-0x49jKF2Gp5mqLKqGxtjt4gKdD80pjW6OXNgG0QI2hz2RkF3bi_Ax2osqoJHy870xkIwg0VLB1P7F_SwhQAztII92BmK4xfvk7ctdF5_OJ03yc_b5WbxI10_3FWLb-tU5SULKWGaM2iwyAuAtmgF5LTJcsgbXWSatw2uCa45x0ww3tRclXnBYlUcqxYUozfJl-O7ezf8HuOvZW-80l0HVg-jlwRzWmSkpCKin1-hu2F0Nk4nCSEl5kUueKQ-naix7nUj98704A7yZccRKI-AcoP3TrdSmfC8kODAdDLDcspTPucppzzllKeMeUaXvnJfnv-_VR2tnQ-w1WcHXDCq0yenyCSfyj_umVGP4KS29C8Tjb2V |
CitedBy_id | crossref_primary_10_1016_j_bbmt_2019_04_006 crossref_primary_10_15789_2220_7619_EOA_1407 crossref_primary_10_4274_jcp_2022_82246 crossref_primary_10_1093_infdis_jiz380 crossref_primary_10_3390_ijerph19138017 crossref_primary_10_1016_j_vaccine_2020_05_067 crossref_primary_10_1016_j_vaccine_2024_126257 crossref_primary_10_3390_vaccines12060695 crossref_primary_10_3390_vaccines7030118 crossref_primary_10_22625_2072_6732_2021_13_4_106_112 crossref_primary_10_1016_j_jiac_2019_05_005 crossref_primary_10_1016_j_tmaid_2018_08_006 crossref_primary_10_1016_j_vaccine_2024_126527 crossref_primary_10_3201_eid3005_231757 crossref_primary_10_3928_19382359_20200220_01 crossref_primary_10_46235_1028_7221_16572_DOT crossref_primary_10_2188_jea_JE20200455 crossref_primary_10_3390_ijms26051801 crossref_primary_10_3390_v13101982 crossref_primary_10_3390_v15010171 crossref_primary_10_7883_yoken_JJID_2018_500 crossref_primary_10_1016_j_jiac_2021_04_006 crossref_primary_10_22141_2312_413X_9_5_6_2021_246693 crossref_primary_10_31631_2073_3046_2019_18_4_34_40 crossref_primary_10_1007_s40278_019_56445_3 crossref_primary_10_1371_journal_pone_0218782 crossref_primary_10_1007_s10654_019_00569_4 crossref_primary_10_1016_j_jiac_2022_03_025 crossref_primary_10_1016_j_ijid_2020_09_1458 crossref_primary_10_1017_S095026881800211X crossref_primary_10_3390_v14081716 crossref_primary_10_1371_journal_pbio_3001685 crossref_primary_10_1016_j_vaccine_2020_01_067 crossref_primary_10_3389_fmicb_2019_01470 crossref_primary_10_3390_ijerph18010009 crossref_primary_10_3390_v13101970 crossref_primary_10_2807_1560_7917_ES_2024_29_22_2400275 crossref_primary_10_1093_cid_ciz363 |
Cites_doi | 10.1093/infdis/jir098 10.2807/1560-7917.ES.2017.22.42.17-00673 10.1016/j.vaccine.2017.09.026 10.1016/S0140-6736(14)62331-X 10.1093/infdis/jis923 10.5365/wpsar.2015.6.4.007 10.1371/journal.pone.0168222 10.1093/cid/ciu105 10.1002/jmv.21372 10.7883/yoken.63.225 10.1016/j.ijid.2016.10.029 10.7883/yoken.JJID.2005.98 10.1007/s00430-016-0451-4 10.1128/CDLI.11.1.119-122.2004 10.1017/S0950268817001248 |
ContentType | Journal Article |
Copyright | Authors Copyright Japan Science and Technology Agency 2018 |
Copyright_xml | – notice: Authors – notice: Copyright Japan Science and Technology Agency 2018 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7T5 7T7 7TK 7U9 8FD C1K FR3 H94 M7N P64 7X8 |
DOI | 10.7883/yoken.JJID.2018.083 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Virology and AIDS Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1884-2836 |
EndPage | 418 |
ExternalDocumentID | 29962488 10_7883_yoken_JJID_2018_083 article_yoken_71_6_71_JJID_2018_083_article_char_en |
Genre | Journal Article |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GroupedDBID | --- .55 29J 2WC 53G 5GY ACPRK ADBBV AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL DIK DU5 E3Z EBS EJD F5P FRP GX1 JSF JSH KQ8 OK1 RJT RNS RZJ TR2 W2D X7M XSB AAYXX CITATION OVT CGR CUY CVF ECM EIF NPM 7QL 7T5 7T7 7TK 7U9 8FD C1K FR3 H94 M7N P64 7X8 |
ID | FETCH-LOGICAL-c594t-24e64ad0857aaf7f8a53d15a5de71e6fd0b20b6604846db6c95746c9c60cfac43 |
ISSN | 1344-6304 1884-2836 |
IngestDate | Thu Jul 10 22:29:42 EDT 2025 Mon Jun 30 12:01:02 EDT 2025 Thu Jan 02 23:04:04 EST 2025 Tue Jul 01 03:55:13 EDT 2025 Thu Apr 24 22:50:44 EDT 2025 Thu Aug 17 20:30:59 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | primary case imported measles elimination era vaccination |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c594t-24e64ad0857aaf7f8a53d15a5de71e6fd0b20b6604846db6c95746c9c60cfac43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/yoken/71/6/71_JJID.2018.083/_article/-char/en |
PMID | 29962488 |
PQID | 2229067586 |
PQPubID | 2048383 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_2063712938 proquest_journals_2229067586 pubmed_primary_29962488 crossref_citationtrail_10_7883_yoken_JJID_2018_083 crossref_primary_10_7883_yoken_JJID_2018_083 jstage_primary_article_yoken_71_6_71_JJID_2018_083_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018/11/30 |
PublicationDateYYYYMMDD | 2018-11-30 |
PublicationDate_xml | – month: 11 year: 2018 text: 2018/11/30 day: 30 |
PublicationDecade | 2010 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan – name: Tokyo |
PublicationTitle | Japanese Journal of Infectious Diseases |
PublicationTitleAlternate | Jpn J Infect Dis |
PublicationYear | 2018 |
Publisher | National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee Japan Science and Technology Agency |
Publisher_xml | – name: National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee – name: Japan Science and Technology Agency |
References | 21. Ching PK, Zapanta MJ, de Los Reyes VC, et al. Investigation of a measles outbreak in Cordillera, Northern Philippines, 2013. Western Pac Surveill Response J. 2016;7:1-5. 22. Zheng X, Zhang N, Zhang X, et al. Correction: investigation of a measles outbreak in China to identify gaps in vaccination coverage, routes of transmission, and interventions. PLoS One. 2016;11:e0168222. 16. Mizuta K, Abiko C, Murata T, et al. An outbreak of measles virus infection due to a genotype D9 at a junior high school in Yamagata, Japan in 2004. Jpn J Infect Dis. 2005;58:98-100. 2. Holzmann H, Hengel H, Tenbusch M, et al. Eradication of measles: remaining challenges. Med Microbiol Immunol. 2016;205:201-8. 4. World Health Organization. Global Measles and Rubella Strategic Plan 2012–2020. Available at <http://apps.who.int/iris/bitstream/10665/44855/1/9789241503396_eng.pdf>. Accessed January 23, 2018. 24. Nagai M, Xin JY, Yoshida N, et al. Modified adult measles in outbreaks in Japan, 2007–2008. J Med Virol. 2009;81:1094-101. 5. World Health Organization Regional Office for the Western Pacific. Brunei Darussalam, Cambodia, Japan verified as achieving measles elimination. Available at <http://www.wpro.who.int/mediacentre/releases/2015/20150327/en/>. Accessed October 2, 2017. 1. Griffin DE. Measles virus. In: Knipe DM, Howley PM, editors. Fields Virology, 6th ed. Philadelphia, PA: Wolters Kluwer; 2013. p.1042-69. 8. Inaida S, Matsuno S, Kobune F. Measles elimination and immunisation: national surveillance trends in Japan, 2008–2015. Epidemiol Infect. 2017;145:2374-81. 25. Akiyoshi K, Suga T, Nukuzuma S, et al. Reevaluation of laboratory methods for diagnosis of measles. Jpn J Infect Dis. 2010;63:225-8. 20. De Serres G, Markowski F, Toth E, et al. Largest measles epidemic in North America in a decade--Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events. J Infect Dis. 2013;207:990-8. 7. National Institute of Infectious Diseases. About measles. Updated on June 7, 2017. Available at <https://www.niid.go.jp/niid/ja/kansennohanashi/518-measles.html>. Accessed October 2, 2017. Japanese. 19. Currie J, Davies L, McCarthy J, et al. Measles outbreak linked to European B3 outbreaks, Wales, United Kingdom, 2017. Euro Surveill. 2017;22:42. 17. Hartoyo E, Wiyatno A, Jaya UA, et al. Occurrence of measles genotype D8 during a 2014 outbreak in Banjarmasin, South Kalimantan, Indonesia. Int J Infect Dis. 2017;54:1-3. 23. Quarantine Information Office, Ministry of Health, Labour, and Welfare. Website for travelers’ health. Available at <http://www.forth.go.jp/useful/vaccination.html>. Accessed January 29, 2018. Japanese. 3. World Health Organization. Measles fact sheet, updated in July 2017. Available at <http://www.who.int/mediacentre/factsheets/fs286/en/>. Accessed October 2, 2017. 12. Rosen JB, Rota JS, Hickman CJ, et al. Outbreak of measles among persons with prior evidence of immunity, New York city, 2011. Clin Infect Dis. 2014;58:1205-10. 13. Rota JS, Hickman CJ, Sowers SB, et al. Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission. J Infect Dis. 2011;204:S559-63. 26. Pannuti CS, Morello RJ, Moraes JC, et al. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic. Clin Diagn Lab Immunol. 2004;11:119-22. 15. National Institute of Infectious Diseases. The section of measles in the laboratory manual for pathogen detection, version 3.4. 2017. Avairable at <https://www.niid.go.jp/niid/images/lab-manual/measles.v3-4.2017Mar.pdf>. Accessed September 19, 2017. Japanese. 6. Ministry of Health, Labour and Welfare. The guideline for the prevention of specific infectious diseases: measles. Available at <http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000112477.pdf>. Accessed October 2, 2017. Japanese. 11. Centers for Disease Control and Prevention (CDC). Epidemiology and Prevention of Vaccine-Preventable Diseases, 13th Edition, Chapter 13, Measles. Available at <https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/meas.pdf>. Accessed October 2, 2017. 10. National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare. Measles in Japan, 2016. Infect Agents Surveillance Rep. 2017;38:45’-7. Available at <https://www0.niid.go.jp/niid/idsc/iasr/38/445e.pdf>. Accessed January 10, 2018. 14. Katz SL. Measles (Rubeola). In: Gershon AA, Hotez PJ, Katz SL, editors. Krugman’s Infectious Disease of Children. 11th ed. Denvers, CO: Mosby; 2004. p. 353-71. 9. Ministry of Internal Affairs and Communications. Review of the target age for the vaccination of measles. Available at <http://www.soumu.go.jp/main_sosiki/hyouka/pdf/100408_4.pdf>. Accessed December 13, 2017. Japanese. 18. Giesecke J. Primary and index cases. Lancet. 2014;384:2024. 22 23 24 25 26 10 11 12 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 |
References_xml | – reference: 11. Centers for Disease Control and Prevention (CDC). Epidemiology and Prevention of Vaccine-Preventable Diseases, 13th Edition, Chapter 13, Measles. Available at <https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/meas.pdf>. Accessed October 2, 2017. – reference: 9. Ministry of Internal Affairs and Communications. Review of the target age for the vaccination of measles. Available at <http://www.soumu.go.jp/main_sosiki/hyouka/pdf/100408_4.pdf>. Accessed December 13, 2017. Japanese. – reference: 19. Currie J, Davies L, McCarthy J, et al. Measles outbreak linked to European B3 outbreaks, Wales, United Kingdom, 2017. Euro Surveill. 2017;22:42. – reference: 21. Ching PK, Zapanta MJ, de Los Reyes VC, et al. Investigation of a measles outbreak in Cordillera, Northern Philippines, 2013. Western Pac Surveill Response J. 2016;7:1-5. – reference: 22. Zheng X, Zhang N, Zhang X, et al. Correction: investigation of a measles outbreak in China to identify gaps in vaccination coverage, routes of transmission, and interventions. PLoS One. 2016;11:e0168222. – reference: 14. Katz SL. Measles (Rubeola). In: Gershon AA, Hotez PJ, Katz SL, editors. Krugman’s Infectious Disease of Children. 11th ed. Denvers, CO: Mosby; 2004. p. 353-71. – reference: 6. Ministry of Health, Labour and Welfare. The guideline for the prevention of specific infectious diseases: measles. Available at <http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000112477.pdf>. Accessed October 2, 2017. Japanese. – reference: 3. World Health Organization. Measles fact sheet, updated in July 2017. Available at <http://www.who.int/mediacentre/factsheets/fs286/en/>. Accessed October 2, 2017. – reference: 10. National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare. Measles in Japan, 2016. Infect Agents Surveillance Rep. 2017;38:45’-7. Available at <https://www0.niid.go.jp/niid/idsc/iasr/38/445e.pdf>. Accessed January 10, 2018. – reference: 23. Quarantine Information Office, Ministry of Health, Labour, and Welfare. Website for travelers’ health. Available at <http://www.forth.go.jp/useful/vaccination.html>. Accessed January 29, 2018. Japanese. – reference: 17. Hartoyo E, Wiyatno A, Jaya UA, et al. Occurrence of measles genotype D8 during a 2014 outbreak in Banjarmasin, South Kalimantan, Indonesia. Int J Infect Dis. 2017;54:1-3. – reference: 7. National Institute of Infectious Diseases. About measles. Updated on June 7, 2017. Available at <https://www.niid.go.jp/niid/ja/kansennohanashi/518-measles.html>. Accessed October 2, 2017. Japanese. – reference: 15. National Institute of Infectious Diseases. The section of measles in the laboratory manual for pathogen detection, version 3.4. 2017. Avairable at <https://www.niid.go.jp/niid/images/lab-manual/measles.v3-4.2017Mar.pdf>. Accessed September 19, 2017. Japanese. – reference: 8. Inaida S, Matsuno S, Kobune F. Measles elimination and immunisation: national surveillance trends in Japan, 2008–2015. Epidemiol Infect. 2017;145:2374-81. – reference: 18. Giesecke J. Primary and index cases. Lancet. 2014;384:2024. – reference: 12. Rosen JB, Rota JS, Hickman CJ, et al. Outbreak of measles among persons with prior evidence of immunity, New York city, 2011. Clin Infect Dis. 2014;58:1205-10. – reference: 20. De Serres G, Markowski F, Toth E, et al. Largest measles epidemic in North America in a decade--Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events. J Infect Dis. 2013;207:990-8. – reference: 25. Akiyoshi K, Suga T, Nukuzuma S, et al. Reevaluation of laboratory methods for diagnosis of measles. Jpn J Infect Dis. 2010;63:225-8. – reference: 24. Nagai M, Xin JY, Yoshida N, et al. Modified adult measles in outbreaks in Japan, 2007–2008. J Med Virol. 2009;81:1094-101. – reference: 1. Griffin DE. Measles virus. In: Knipe DM, Howley PM, editors. Fields Virology, 6th ed. Philadelphia, PA: Wolters Kluwer; 2013. p.1042-69. – reference: 4. World Health Organization. Global Measles and Rubella Strategic Plan 2012–2020. Available at <http://apps.who.int/iris/bitstream/10665/44855/1/9789241503396_eng.pdf>. Accessed January 23, 2018. – reference: 2. Holzmann H, Hengel H, Tenbusch M, et al. Eradication of measles: remaining challenges. Med Microbiol Immunol. 2016;205:201-8. – reference: 26. Pannuti CS, Morello RJ, Moraes JC, et al. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic. Clin Diagn Lab Immunol. 2004;11:119-22. – reference: 5. World Health Organization Regional Office for the Western Pacific. Brunei Darussalam, Cambodia, Japan verified as achieving measles elimination. Available at <http://www.wpro.who.int/mediacentre/releases/2015/20150327/en/>. Accessed October 2, 2017. – reference: 13. Rota JS, Hickman CJ, Sowers SB, et al. Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission. J Infect Dis. 2011;204:S559-63. – reference: 16. Mizuta K, Abiko C, Murata T, et al. An outbreak of measles virus infection due to a genotype D9 at a junior high school in Yamagata, Japan in 2004. Jpn J Infect Dis. 2005;58:98-100. – ident: 13 doi: 10.1093/infdis/jir098 – ident: 19 doi: 10.2807/1560-7917.ES.2017.22.42.17-00673 – ident: 4 doi: 10.1016/j.vaccine.2017.09.026 – ident: 18 doi: 10.1016/S0140-6736(14)62331-X – ident: 20 doi: 10.1093/infdis/jis923 – ident: 10 – ident: 14 – ident: 21 doi: 10.5365/wpsar.2015.6.4.007 – ident: 9 – ident: 7 – ident: 22 doi: 10.1371/journal.pone.0168222 – ident: 3 – ident: 12 doi: 10.1093/cid/ciu105 – ident: 5 – ident: 1 – ident: 11 – ident: 24 doi: 10.1002/jmv.21372 – ident: 25 doi: 10.7883/yoken.63.225 – ident: 17 doi: 10.1016/j.ijid.2016.10.029 – ident: 15 – ident: 16 doi: 10.7883/yoken.JJID.2005.98 – ident: 2 doi: 10.1007/s00430-016-0451-4 – ident: 26 doi: 10.1128/CDLI.11.1.119-122.2004 – ident: 6 – ident: 8 doi: 10.1017/S0950268817001248 – ident: 23 |
SSID | ssj0025510 |
Score | 2.3522854 |
Snippet | The incidence of modified measles (M-Me), characterized by milder symptoms than those of typical measles (T-Me), has been increasing in Japan. However, the... |
SourceID | proquest pubmed crossref jstage |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 413 |
SubjectTerms | Adolescent Adult Child Child, Preschool Communicable Disease Control - methods Communicable Diseases, Imported - epidemiology Communicable Diseases, Imported - pathology Communicable Diseases, Imported - prevention & control Communicable Diseases, Imported - transmission Disease Outbreaks Disease Transmission, Infectious elimination era Epidemics Epidemiology Female Genomes Genotype Genotypes Humans Immunity Importation imported measles Incidence Infant Japan - epidemiology Male Measles Measles - epidemiology Measles - pathology Measles - prevention & control Measles - transmission Measles Vaccine - administration & dosage Measles Vaccine - immunology Measles virus - classification Measles virus - genetics Measles virus - isolation & purification Middle Aged Outbreaks primary case Signs and symptoms vaccination Vaccines Viruses Young Adult |
Title | The Largest Measles Outbreak, Including 38 Modified Measles and 22 Typical Measles Cases in Its Elimination Era in Yamagata, Japan, 2017 |
URI | https://www.jstage.jst.go.jp/article/yoken/71/6/71_JJID.2018.083/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/29962488 https://www.proquest.com/docview/2229067586 https://www.proquest.com/docview/2063712938 |
Volume | 71 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Japanese Journal of Infectious Diseases, 2018/11/30, Vol.71(6), pp.413-418 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELe2gRAviG8KAxmJtzaldRwnfYTRsU0MHrZJ21PkJM6WtU2nJXnY_gL-bO5sx2tR-Zp4sdqLHdk5_3x39p2PkHcjPoyEz6THfC49nmVDbyTR0TUHdR2AmaQ6nc_-V7FzxPeOg-O19e0Fr6WmTvrp9cq4kttwFWjAV4yS_QfOupcCAX4Df6EEDkP51zz-gq7cVd3dV7Kaqqr7DQYGiuDEgn_a6KgVP8KsZ0WOCmdbE7fMGeuCJaoZ1ZK3QK5pJ9ndukKvL_SV0ZNkfCmRfCJn8lTW1sf2wmyggoAPl_RcfKCqNuxsaiJWjN9XU-Gdn3gsdHOQNJ_JRF5hYicbLFSkZ4Xb_VG1OR9qynNHPJSlnOhOHJwV183EiZeDBv7p15w0i3saw6i9S7F1-Wj3QZccJlb00o30zwPqjrMCr13RWzKzWVHXSi2s-z7nnvBNJuS-MrQo4h5oX2JRWJh8MRYUiys_NyG1VongRqj8LJ_CKMJ7Mq7mE1X29_Z2P6FvYdQfRP6NOHZOknZaxbp2HA5jgQW2irFVDK3itg6G6AEi1skdBuYSZvL4fOxcncBqNLdytIM0t29hZ96v6MqShnb3HIyUU_Vr-0vrYYcPyQP7-ekH06VHZE2Vj8m9fesi8oR8B1BQCwpq5zRtQdGjDhLUj2gLCVcPIEEZoxYSjqwhQYuSAiToAiQoQALJLSR6VE-THkU4PCVH2-PDrR3Pphvx0mDEa49xJbjMMOWDlHmYRzLws2Egg0yFQyXybJCwQSIEyDwuskSkoyDkUKZikOYy5f4zslHOS_WCUJXwNOFykKLjrsAorEEoUjHK_ITlQOgQ1n7iOLV38WNKmGkMNjnyxTJ9idkd0nONLsxVNL-v_tHwzlW-xYTqkM2W77Fd-KqY6RwRYRCJDnnrHoNYwrNGwCLADl4o_BBtiahDnpv54voBGrBgoDi8_B89fEXu36wgm2SjvmzUa7AT6uSNBsEPx3EXhg |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Largest+Measles+Outbreak%2C+Including+38+Modified+Measles+and+22+Typical+Measles+Cases+in+Its+Elimination+Era+in+Yamagata%2C+Japan%2C+2017&rft.jtitle=Japanese+Journal+of+Infectious+Diseases&rft.au=Komabayashi%2C+Kenichi&rft.au=Seto%2C+Junji&rft.au=Tanaka%2C+Shizuka&rft.au=Suzuki%2C+Yu&rft.date=2018-11-30&rft.pub=National+Institute+of+Infectious+Diseases%2C+Japanese+Journal+of+Infectious+Diseases+Editorial+Committee&rft.issn=1344-6304&rft.eissn=1884-2836&rft.volume=71&rft.issue=6&rft.spage=413&rft.epage=418&rft_id=info:doi/10.7883%2Fyoken.JJID.2018.083&rft.externalDocID=article_yoken_71_6_71_JJID_2018_083_article_char_en |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1344-6304&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1344-6304&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1344-6304&client=summon |